International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation

V. Eleftheriadou, I. Hamzavi, A. G. Pandya, P. Grimes, J. E. Harris, R. H. Huggins, H. W. Lim, N. Elbuluk, B. Bhatia, A. Tovar-Garza, A. F. Nahhas, T. Braunberger, K. Ezzedine

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: There is no cure or firm clinical recommendations for the treatment of vitiligo. One of the main issues is the heterogeneity of outcome measures used in randomized controlled trials for vitiligo. Objectives: To define successful repigmentation from the patients’ point of view and to propose how and when repigmentation should be evaluated in clinical trials in vitiligo. Methods: We conducted three workshops with patients with vitiligo and their parents or caregivers. Workshop 1 was held at World Vitiligo Day (Detroit, MI), workshop 2 at the University of Texas Southwestern Medical Center and workshop 3 at the Vitiligo and Pigmentation Institute of Southern California, University of California. Results: Seventy-three participants were recruited. Consensus on the following questions was achieved unanimously: (i) the definition of ‘successful repigmentation’ was 80–100% of repigmentation of a target lesion and (ii) both an objective and a subjective scale to measure repigmentation should be used. Conclusions: This was the largest patients’ outcomes workshop. We followed the guidance from the CSG-COUSIN and the Vitiligo Global Issues Consensus Group. Our recommendations to use percentage of repigmentation quartiles (0–25%, 26–50%, 51–79%, 80–100%) and the Vitiligo Noticeability Scale are based on the best available current evidence. A limitation of the research is that the workshops were conducted only in the U.S.A., due to pre-existing organisational support and the availability of funding.

Original languageEnglish (US)
JournalBritish Journal of Dermatology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Vitiligo
Education
Consensus
Pigmentation
Caregivers
Randomized Controlled Trials
Parents
Outcome Assessment (Health Care)
Clinical Trials

ASJC Scopus subject areas

  • Dermatology

Cite this

Eleftheriadou, V., Hamzavi, I., Pandya, A. G., Grimes, P., Harris, J. E., Huggins, R. H., ... Ezzedine, K. (Accepted/In press). International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation. British Journal of Dermatology. https://doi.org/10.1111/bjd.17013

International Initiative for Outcomes (INFO) for vitiligo : workshops with patients with vitiligo on repigmentation. / Eleftheriadou, V.; Hamzavi, I.; Pandya, A. G.; Grimes, P.; Harris, J. E.; Huggins, R. H.; Lim, H. W.; Elbuluk, N.; Bhatia, B.; Tovar-Garza, A.; Nahhas, A. F.; Braunberger, T.; Ezzedine, K.

In: British Journal of Dermatology, 01.01.2018.

Research output: Contribution to journalArticle

Eleftheriadou, V, Hamzavi, I, Pandya, AG, Grimes, P, Harris, JE, Huggins, RH, Lim, HW, Elbuluk, N, Bhatia, B, Tovar-Garza, A, Nahhas, AF, Braunberger, T & Ezzedine, K 2018, 'International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation', British Journal of Dermatology. https://doi.org/10.1111/bjd.17013
Eleftheriadou, V. ; Hamzavi, I. ; Pandya, A. G. ; Grimes, P. ; Harris, J. E. ; Huggins, R. H. ; Lim, H. W. ; Elbuluk, N. ; Bhatia, B. ; Tovar-Garza, A. ; Nahhas, A. F. ; Braunberger, T. ; Ezzedine, K. / International Initiative for Outcomes (INFO) for vitiligo : workshops with patients with vitiligo on repigmentation. In: British Journal of Dermatology. 2018.
@article{aa64d5708ae74809aafb3cb5b5b38533,
title = "International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation",
abstract = "Background: There is no cure or firm clinical recommendations for the treatment of vitiligo. One of the main issues is the heterogeneity of outcome measures used in randomized controlled trials for vitiligo. Objectives: To define successful repigmentation from the patients’ point of view and to propose how and when repigmentation should be evaluated in clinical trials in vitiligo. Methods: We conducted three workshops with patients with vitiligo and their parents or caregivers. Workshop 1 was held at World Vitiligo Day (Detroit, MI), workshop 2 at the University of Texas Southwestern Medical Center and workshop 3 at the Vitiligo and Pigmentation Institute of Southern California, University of California. Results: Seventy-three participants were recruited. Consensus on the following questions was achieved unanimously: (i) the definition of ‘successful repigmentation’ was 80–100{\%} of repigmentation of a target lesion and (ii) both an objective and a subjective scale to measure repigmentation should be used. Conclusions: This was the largest patients’ outcomes workshop. We followed the guidance from the CSG-COUSIN and the Vitiligo Global Issues Consensus Group. Our recommendations to use percentage of repigmentation quartiles (0–25{\%}, 26–50{\%}, 51–79{\%}, 80–100{\%}) and the Vitiligo Noticeability Scale are based on the best available current evidence. A limitation of the research is that the workshops were conducted only in the U.S.A., due to pre-existing organisational support and the availability of funding.",
author = "V. Eleftheriadou and I. Hamzavi and Pandya, {A. G.} and P. Grimes and Harris, {J. E.} and Huggins, {R. H.} and Lim, {H. W.} and N. Elbuluk and B. Bhatia and A. Tovar-Garza and Nahhas, {A. F.} and T. Braunberger and K. Ezzedine",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/bjd.17013",
language = "English (US)",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - International Initiative for Outcomes (INFO) for vitiligo

T2 - workshops with patients with vitiligo on repigmentation

AU - Eleftheriadou, V.

AU - Hamzavi, I.

AU - Pandya, A. G.

AU - Grimes, P.

AU - Harris, J. E.

AU - Huggins, R. H.

AU - Lim, H. W.

AU - Elbuluk, N.

AU - Bhatia, B.

AU - Tovar-Garza, A.

AU - Nahhas, A. F.

AU - Braunberger, T.

AU - Ezzedine, K.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: There is no cure or firm clinical recommendations for the treatment of vitiligo. One of the main issues is the heterogeneity of outcome measures used in randomized controlled trials for vitiligo. Objectives: To define successful repigmentation from the patients’ point of view and to propose how and when repigmentation should be evaluated in clinical trials in vitiligo. Methods: We conducted three workshops with patients with vitiligo and their parents or caregivers. Workshop 1 was held at World Vitiligo Day (Detroit, MI), workshop 2 at the University of Texas Southwestern Medical Center and workshop 3 at the Vitiligo and Pigmentation Institute of Southern California, University of California. Results: Seventy-three participants were recruited. Consensus on the following questions was achieved unanimously: (i) the definition of ‘successful repigmentation’ was 80–100% of repigmentation of a target lesion and (ii) both an objective and a subjective scale to measure repigmentation should be used. Conclusions: This was the largest patients’ outcomes workshop. We followed the guidance from the CSG-COUSIN and the Vitiligo Global Issues Consensus Group. Our recommendations to use percentage of repigmentation quartiles (0–25%, 26–50%, 51–79%, 80–100%) and the Vitiligo Noticeability Scale are based on the best available current evidence. A limitation of the research is that the workshops were conducted only in the U.S.A., due to pre-existing organisational support and the availability of funding.

AB - Background: There is no cure or firm clinical recommendations for the treatment of vitiligo. One of the main issues is the heterogeneity of outcome measures used in randomized controlled trials for vitiligo. Objectives: To define successful repigmentation from the patients’ point of view and to propose how and when repigmentation should be evaluated in clinical trials in vitiligo. Methods: We conducted three workshops with patients with vitiligo and their parents or caregivers. Workshop 1 was held at World Vitiligo Day (Detroit, MI), workshop 2 at the University of Texas Southwestern Medical Center and workshop 3 at the Vitiligo and Pigmentation Institute of Southern California, University of California. Results: Seventy-three participants were recruited. Consensus on the following questions was achieved unanimously: (i) the definition of ‘successful repigmentation’ was 80–100% of repigmentation of a target lesion and (ii) both an objective and a subjective scale to measure repigmentation should be used. Conclusions: This was the largest patients’ outcomes workshop. We followed the guidance from the CSG-COUSIN and the Vitiligo Global Issues Consensus Group. Our recommendations to use percentage of repigmentation quartiles (0–25%, 26–50%, 51–79%, 80–100%) and the Vitiligo Noticeability Scale are based on the best available current evidence. A limitation of the research is that the workshops were conducted only in the U.S.A., due to pre-existing organisational support and the availability of funding.

UR - http://www.scopus.com/inward/record.url?scp=85054478008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054478008&partnerID=8YFLogxK

U2 - 10.1111/bjd.17013

DO - 10.1111/bjd.17013

M3 - Article

C2 - 30030843

AN - SCOPUS:85054478008

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

ER -